Barbara Jungwirth is an experienced freelance journalist, writer, and translator who has been reporting on HIV for TheBody and TheBodyPro since 2002. Specializing in technical summaries of published and presented research on HIV and related topics, Barbara has been the primary author of TheBodyPro's "This Week in HIV Research" series since 2014.

Latest by Barbara Jungwirth

This Week in HIV Research: One Step at a Time

June 13, 2019: Integrated stepped alcohol treatment in HIV clinics; cytokines, inflammation, and heart risk; impact of CCR5 gene editing on lifespan; the costs of "test and treat" for hepatitis C.

By Barbara Jungwirth and Myles Helfand

This Week in HIV Research: The Racism of Perceived Risk

June 6, 2019: HIV/STI risk perceptions differ by race; psychosocial issues and HIV risk among young trans women; switching to dolutegravir/atazanavir; reports of severe hepatotoxicity on dolutegravir.

By Barbara Jungwirth and Myles Helfand

This Week in HIV Research: Matters of the Heart

May 30, 2019: Myocardial infarction risk among people with HIV; dolutegravir vs. efavirenz; a new way to estimate date of seroconversion; identifying people at imminent risk for disengagement from care.

By Barbara Jungwirth and Myles Helfand

This Week in HIV Research: I Screen, You Screen, We All Screen for HPV-Related Cancers

May 23, 2019: How CD4 variables over time affect anal cancer risk; when to consider anal pap smears for women; switching from E/C/F/TAF to ABC/3TC; new data on marijuana use among people with HIV.

By Barbara Jungwirth and Myles Helfand

Researchers Recommend Screening All People With HIV for Elevated Liver Function Values

Authors of a literature review note the high prevalence of liver disease among people with HIV and recommend a step-by-step approach to management.

By Barbara Jungwirth

This Week in HIV Research: A Test of Resistance

May 16, 2019: The dwindling value of baseline genotype testing; severe insomnia and cardiovascular disease; cardiovascular risk stratified by sex among people over 50; the persistence of racial disparities among women diagnosed with HIV.

By Barbara Jungwirth and Myles Helfand

This Week in HIV Research: Better Serving the Underserved

May 9, 2019: HIV care retention and viral suppression among transgender women; heating opioid use equipment to curb HIV transmission; managing HIV outbreaks among people who are homeless; improving viral suppression among people who use substances.

By Barbara Jungwirth and Myles Helfand

This Week in HIV Research: Unexpected Outcomes

May 2, 2019: patient-centered care model improves viral suppression; subpar immune responses when baseline CD4 tops 500; when CD4 plummets despite viral suppression; vaccination, immunoglobulin, and hepatitis A exposure.

By Barbara Jungwirth and Myles Helfand

This Week in HIV Research: Disparities Drive the Epidemic

April 25, 2019: stigma and viral load among African-American women; U.S. HIV incidence sans racial disparities; the care continuum is failing young MSM; a moment of reckoning regarding HIV among U.S. youth.

By Barbara Jungwirth and Myles Helfand

Why Do Study Participants Misreport Their HIV Status?

A new study demonstrates the phenomenon, but experts say more research needs to determine why it occurs -- and what researchers can do differently to reduce it.

By Barbara Jungwirth